OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
475660$5200.0057

S-Chem Co Ltd

Commodity ChemicalsVerified

S-Chem Co Ltd has a market price of 5,200 KRW and a market cap of 41.24 trillion KRW, with a price-to-book ratio of 1.14 and a price-to-tangible-book ratio of 1.14. The company's liquidity position is characterized by a current ratio of 5.4, indicating strong short-term liquidity, but its operating cash flow is negative at -971.36 billion KRW, and free cash flow is also negative at -5.70 trillion KRW. The company's capital structure is supported by a low debt-to-equity ratio of 0.03, with long-term debt of 1.22 trillion KRW and total equity of 36.09 trillion KRW. Profitability metrics show a challenging performance, with a return on equity of -6.01% and a return on assets of -5.46%. The company reported a net loss of 2.17 trillion KRW and an operating loss of 2.03 trillion KRW, with a gross profit of 4.76 trillion KRW on revenue of 22.10 trillion KRW. These figures fall below the industry median for return on equity and return on assets, indicating underperformance relative to peers in the Commodity Chemicals industry. The company's revenue is distributed across four segments: OLED materials, Health Care, Secondary Battery, and R&D/OEM. The OLED segment is the primary revenue driver, with the Health Care and Secondary Battery segments contributing to a lesser extent. The R&D/OEM segment is focused on innovation and partnerships. However, the company's revenue concentration is not disclosed, and there is no indication of geographic diversification in the provided data. The company's growth trajectory is uncertain, with no specific revenue growth or decline percentages provided for the current or next fiscal year. The capital expenditure of -6.24 trillion KRW indicates significant investment in the business, but the negative operating and free cash flows suggest that the company is not generating sufficient cash to support these investments. The company faces a medium liquidity risk due to negative net cash after subtracting total debt. The risk of dilution is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's valuation is adjusted for liquidity and other factors, but no specific adjustments are detailed in the provided data. Recent events and filings do not provide specific details on the company's operations or financial performance beyond the disclosed financial snapshot. The company's risk assessment highlights the need for improved cash flow generation and liquidity management to support its capital expenditures and operational needs.

30-day price · 475660-720.00 (-13.3%)
Low$4540.00High$6000.00Close$4680.00As of18 May, 00:00 UTC
Profile
CompanyS-Chem Co Ltd
Ticker475660.KQ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. S-Chem Co Ltd is a Korea-based company engaged in the manufacturing of organic material synthesis, operating through four segments: OLED materials, Health Care, Secondary Battery, and R&D/OEM.

Classification. S-Chem is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

S-Chem Co Ltd has a market price of 5,200 KRW and a market cap of 41.24 trillion KRW, with a price-to-book ratio of 1.14 and a price-to-tangible-book ratio of 1.14. The company's liquidity position is characterized by a current ratio of 5.4, indicating strong short-term liquidity, but its operating cash flow is negative at -971.36 billion KRW, and free cash flow is also negative at -5.70 trillion KRW. The company's capital structure is supported by a low debt-to-equity ratio of 0.03, with long-term debt of 1.22 trillion KRW and total equity of 36.09 trillion KRW. Profitability metrics show a challenging performance, with a return on equity of -6.01% and a return on assets of -5.46%. The company reported a net loss of 2.17 trillion KRW and an operating loss of 2.03 trillion KRW, with a gross profit of 4.76 trillion KRW on revenue of 22.10 trillion KRW. These figures fall below the industry median for return on equity and return on assets, indicating underperformance relative to peers in the Commodity Chemicals industry. The company's revenue is distributed across four segments: OLED materials, Health Care, Secondary Battery, and R&D/OEM. The OLED segment is the primary revenue driver, with the Health Care and Secondary Battery segments contributing to a lesser extent. The R&D/OEM segment is focused on innovation and partnerships. However, the company's revenue concentration is not disclosed, and there is no indication of geographic diversification in the provided data. The company's growth trajectory is uncertain, with no specific revenue growth or decline percentages provided for the current or next fiscal year. The capital expenditure of -6.24 trillion KRW indicates significant investment in the business, but the negative operating and free cash flows suggest that the company is not generating sufficient cash to support these investments. The company faces a medium liquidity risk due to negative net cash after subtracting total debt. The risk of dilution is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's valuation is adjusted for liquidity and other factors, but no specific adjustments are detailed in the provided data. Recent events and filings do not provide specific details on the company's operations or financial performance beyond the disclosed financial snapshot. The company's risk assessment highlights the need for improved cash flow generation and liquidity management to support its capital expenditures and operational needs.
Key takeaways
  • S-Chem Co Ltd has a strong liquidity position with a current ratio of 5.4 but faces challenges with negative operating and free cash flows.
  • The company's profitability metrics, including return on equity and return on assets, are negative, indicating underperformance relative to industry standards.
  • The company's revenue is distributed across four segments, with the OLED segment being the primary driver.
  • The company's growth trajectory is uncertain, with no specific revenue growth or decline percentages provided.
  • The company faces a medium liquidity risk and a low risk of dilution, with no significant dilution potential identified.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$22.10B
Gross profit$4.76B
Operating income-$2.03B
Net income-$2.17B
R&D
SG&A
D&A
SBC
Operating cash flow-$971.4M
CapEx-$6.24B
Free cash flow-$5.70B
Total assets$39.68B
Total liabilities$3.59B
Total equity$36.09B
Cash & equivalents
Long-term debt$1.22B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$5200.00
Market cap$41.24B
Enterprise value$42.46B
P/E
Reported non-GAAP P/E
EV/Revenue1.9
EV/Op income
EV/OCF
P/B1.1
P/Tangible book1.1
Tangible book$36.09B
Net cash-$1.22B
Current ratio5.4
Debt/Equity0.0
ROA-5.5%
ROE-6.0%
Cash conversion45.0%
CapEx/Revenue-28.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric475660Activity
Op margin-9.2%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-9.8%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin21.5%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-28.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity3.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 05:47 UTC#a502bd13
Market quoteclose KRW 5200.00 · shares 0.01B diluted
no public URL
2026-05-03 16:35 UTC#7bcf1570
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 16:37 UTCJob: 8a34cc74